Email Alert | RSS    帮助

中国防痨杂志 ›› 2014, Vol. 36 ›› Issue (11): 927-929.doi: 10.3969/j.issn.1000-6621.2014.11.001

• 专家论坛 •    下一篇

对我国结核病免疫预防策略的探讨

卢锦标 赵爱华 王国治 徐苗   

  1. 100050 北京,中国食品药品检定研究院结核病疫苗室
  • 收稿日期:2014-10-16 出版日期:2014-11-10 发布日期:2014-12-05
  • 通信作者: 徐苗 E-mail:xumiaobj@126.com
  • 基金资助:

    国家“十二五”重大科技专项(2012ZX10004701)

Discussion on the immunoprophylaxis strategy of tuberculosis in China

LU Jin-biao, ZHAO Ai-hua, WANG Guo-zhi, XU Miao   

  1. Division of Tuberculosis Vaccines, National Institutes for Food and Drug Control, Beijing 100050, China
  • Received:2014-10-16 Online:2014-11-10 Published:2014-12-05
  • Contact: XU Miao E-mail:xumiaobj@126.com

摘要: 目前国内外对结核病的预防控制的设想基本达成共识,即在现用卡介苗无可替代的情况下,积极研究新的初免用疫苗、卡介苗初免后加强免疫用疫苗,以及结核分枝杆菌潜伏感染人群用疫苗。这3种类型的结核病新疫苗针对的人群具有各自不同的免疫标识,如何筛查出这些不同类型的人群并采取相应的疫苗进行免疫预防是结核病控制中的重点。作者就上述问题展开探讨,尝试对我国结核病免疫预防策略提出建议。

关键词: 结核/预防和控制, 卡介苗, 接种

Abstract: At present, the domestic and foreign researchers basically reached an agreement on the ideas for the tuberculosis prevention and control. That is, in the case of no substitutes for currently used BCG, researchers should explore new prime vaccines, BCG prime-boosting vaccines and the vaccines for latent tuberculosis infection. These three types of new tuberculosis vaccines will focus on the populations with different immune markers. Therefore, how to screen the different types of people and then vaccinate with the corresponding vaccines is a key point in the TB control. The authors discussed on the above issues and try to propose the views on the immunoprophylaxis strategy of tuberculosis in China.

Key words: Tuberculosis/prevention &, control, BCG vaccine, Vaccination